Logo Image
News|Articles|June 8, 2026

Vaccine Trials at an Inflection Point: Operational, Regulatory, and Public Trust Challenges

From rising costs and regulatory uncertainty to persistent vaccine hesitancy, sponsors face mounting pressure to standardize operations, build community trust, and develop the behavioral capabilities needed to run vaccine trials effectively in a rapidly shifting environment.

The vaccine development landscape is under pressure from multiple directions simultaneously. Sponsors that build flexible, standardized, and community-informed trial programs will be better positioned to absorb regulatory change, accelerate timelines, and earn the public trust that ultimately determines whether vaccines reach the populations who need them.

Related to this article

View more
© putilov_denis - © putilov_denis - stock.adobe.com
Real-Time Clinical Trials Depend on a Scalable EHR-to-EDC Connection
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
Read more
Where AI Leads in Trial Design—and Where Humans Still Need To
Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.
Read more